458 related articles for article (PubMed ID: 22707853)
1. Polymeric conjugates for drug delivery.
Larson N; Ghandehari H
Chem Mater; 2012 Mar; 24(5):840-853. PubMed ID: 22707853
[TBL] [Abstract][Full Text] [Related]
2. HPMA-based polymeric conjugates in anticancer therapeutics.
Rani S; Gupta U
Drug Discov Today; 2020 Jun; 25(6):997-1012. PubMed ID: 32334073
[TBL] [Abstract][Full Text] [Related]
3. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects.
Sandal P; Kumari L; Patel P; Singh A; Singh D; Gupta GD; Kurmi BD
Assay Drug Dev Technol; 2023; 21(4):137-156. PubMed ID: 37083490
[TBL] [Abstract][Full Text] [Related]
5. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
8. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
[TBL] [Abstract][Full Text] [Related]
9. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
10. PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents.
Senevirathne SA; Washington KE; Biewer MC; Stefan MC
J Mater Chem B; 2016 Jan; 4(3):360-370. PubMed ID: 32263202
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
12. The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.
Yang J; Kopeček J
Curr Opin Colloid Interface Sci; 2017 Sep; 31():30-42. PubMed ID: 29276426
[TBL] [Abstract][Full Text] [Related]
13. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
Duncan R; Kopecková P; Strohalm J; Hume IC; Lloyd JB; Kopecek J
Br J Cancer; 1988 Feb; 57(2):147-56. PubMed ID: 3358905
[TBL] [Abstract][Full Text] [Related]
14. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
Duncan R; Vicent MJ
Adv Drug Deliv Rev; 2010 Feb; 62(2):272-82. PubMed ID: 20005271
[TBL] [Abstract][Full Text] [Related]
15. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
[TBL] [Abstract][Full Text] [Related]
16. Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections.
Khan J; Alexander A; Ajazuddin ; Saraf S; Saraf S
Int J Pharm; 2018 Sep; 548(1):500-514. PubMed ID: 29964172
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting.
Etrych T; Strohalm J; Chytil P; Černoch P; Starovoytova L; Pechar M; Ulbrich K
Eur J Pharm Sci; 2011 Apr; 42(5):527-39. PubMed ID: 21392579
[TBL] [Abstract][Full Text] [Related]
18. Polymer Drug Conjugates: Recent Advancements in Various Diseases.
Singh J; Desai S; Yadav S; Narasimhan B; Kaur H
Curr Pharm Des; 2016; 22(19):2821-43. PubMed ID: 26898741
[TBL] [Abstract][Full Text] [Related]
19. Polymer-drug conjugate therapeutics: advances, insights and prospects.
Ekladious I; Colson YL; Grinstaff MW
Nat Rev Drug Discov; 2019 Apr; 18(4):273-294. PubMed ID: 30542076
[TBL] [Abstract][Full Text] [Related]
20. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth.
Naksuriya O; Shi Y; van Nostrum CF; Anuchapreeda S; Hennink WE; Okonogi S
Eur J Pharm Biopharm; 2015 Aug; 94():501-12. PubMed ID: 26134273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
